S&P 500
$5,841.20
-0.1%
-$3.41
DJI
41,832.98
-0.1%
-27.46
NASDAQ
$18,895.70
+0.1%
+$23.05
Bitcoin
111,303.00
+4.3%
+4,582.23
AAPL
$200.40
-0.8%
-$1.69
AMZN
$201.14
+0.0%
+$0.02
GOOG
$174.14
+2.4%
+$4.08
META
$635.06
-0.1%
-$0.44
MSFT
$457.62
+1.1%
+$5.05
NVDA
$132.19
+0.3%
+$0.39
TSLA
$335.28
+0.2%
+$0.66
Iterum Therapeutics Plc (NASDAQ: ITRM)
$0.90
(-5.8%)
-$0.05
Price as of May 21, 2025, 3:15 p.m. ET
Iterum Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Iterum Therapeutics Plc Company Info
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
News & Analysis
Featured Article
Why Iterum Therapeutics Stock Is Crashing Today
The company received disappointing news from the FDA.
Keith Speights | Jul 2, 2021
Featured Article
Why Iterum Therapeutics Stock Soared Today
The FDA gave the company some good news.
Keith Speights | May 28, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.